The KMT2A recombinome of acute leukemias in 2023Claus Meyer, Emmanuelle Clappier, Nicola C. Venn et al.|Leukemia|2023Cited by 214
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Laëtitia Largeaud et al.|Blood|2022Cited by 80
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalentMichele Baccarani, Francesco Passamonti, Ilaria Iacobucci et al.|Leukemia|2019Cited by 9